| Home
> Media > News releases >
Breast Cancer
STUDY FINDS BREAST CONSERVING SURGERY RATES STILL LOW, 10 YEARS
AFTER NIH RECOMMENDS IT FOR ELIGIBLE BREAST CANCER PATIENTS
Northeastern Women, Younger
Women and White Women More Likely To Receive Breast-Conserving Surgery
Top-Performing Hospitals More
Likely to Apply Breast-Conserving Surgeries, Follow-up Radiation
Therapy
Evanston, IL, Jan. 29, 2001 — A clinical research study
released today reveals significant differences in the way U.S.
hospitals manage breast cancer. Women at the nation's top-performing
hospitals are more likely to undergo breast-conserving surgery (BCS)
such as lumpectomy, compared to similar patients at other hospitals,
according to the study from the Solucient Leadership Institute,
formerly the HCIA-Sachs Institute. The National Institutes of Health
recommended BCS for eligible patients over 10 years ago.
The study also finds that:
- Compared to patients in the
Northeast, women in the South are 21 percent less likely to receive
BCS, and women in the West are 17 percent less likely.
- Forty-six
percent of Hispanic women undergo BCS, compared to 47.5 percent of
African-American women, 48.5 percent of Asian Americans, and 51.1
percent of Whites.
- Women insured by Medicaid are 69 percent less
likely than privately insured patients to receive immediate breast
reconstruction following mastectomy.
- Immediate reconstructive
surgery following mastectomy is more common in top-performing
hospitals and teaching hospitals compared to community hospitals.
-
When it comes to radiation therapy following BCS, patients are most
likely to undergo this treatment in top-performing hospitals, as well
as in hospitals in the Western region; moreover, younger patients are
more likely than older patients to receive post-BCS radiation.
"The good news is that top-performing hospitals are clearly
leading the industry in providing more progressive initial treatment
and follow up of breast cancer," says Jean Chenoweth, executive
director of the Solucient Leadership Institute.
"However, an additional area of concern identified in this
study is that women on Medicaid are significantly less likely to have
immediate reconstructive surgery than privately insured women,"
Chenoweth adds. "This underscores the fact that women with breast
cancer may not be being offered the same options, and that some
treatments may not reflect best practice and follow-up care."
According to the National Cancer Institute, one in 10 U.S. women
who live to age 80 will develop breast cancer in their lifetime. More
alarming, breast cancer remains the most common cause of cancer death
among women between ages 35 and 54. However, when detected early and
treated appropriately, breast cancer victims may expect a five-year
survival rate of 95 percent. The two major surgical approaches to
treating breast cancer are BCS and mastectomy.
The purpose of the study, "100 Top Hospitals' Clinical
Research Program: Management of Breast Cancer," was to examine
how top-performing 100 Top Hospitals compare with other hospitals in
each of three outcomes: use of BCS, use of radiation therapy following
BCS, and the performance of immediate breast reconstruction following
mastectomy.
Data from the following sources were compared in the study: the
MedPar database, Solucient's proprietary all payer data base, the
Health Care Financing Administration's Standard Analytical Files (SAF),
and data from winners of the 100 Top Hospitals award, a strictly
empirical evaluation of clinical and financial performance.
About Solucient: The result of a recent merger of HCIA-Sachs with
HBSI, Solucient, headquartered in Evanston, Ill., powers health care
decision-making. As the largest source of health care intelligence and
benchmark information, Solucient provides health care organizations
with access to comprehensive, results-oriented information to grow
their business, contain costs and deliver quality care. Solucient
delivers strategic clinical, operational, financial, planning and
marketing information resulting in improved health care business and
clinical outcomes. Solucient's robust information helps benchmark
performance across the continuum of care.
The Solucient Leadership Institute is the research and education
division of Solucient. The Institute is dedicated to the improvement
of the health care industry through the promulgation of quality
information. The Institute produces 100 Top Hospitals and Clinical
Research Program studies, and publishes white papers — authoritative
research reports, often clinical or financial — that explore the
impact of legislation, new technologies, and clinical breakthrough on
the health care industry.
The Clinical Research Program studies are dedicated to identifying
the treatment patterns of 100 Top Hospitals award winners. The
Institute produces clinical research studies, in conjunction with its
Advisory Board, to improve clinical quality and delivery of care while
providing education to the health care community.
Note: Study excerpts are available via the Internet at
www:100TopHospitals.com. For media copies, please follow the media
link on the Web site's home page or call 212-402-5455 ext. 106.
HEALTH-GRAPHICS from SOLUCIENT
Questions Breast Cancer Patients Should Ask Based on the study
"100 Top Hospitals Clinical Research Program: Management of
Breast Cancer"
- Do I have an encapsulated or slow-growing type of cancer? Or do
I have a fast growing or highly invasive form of cancer?
- What are my treatment options and the likely outcomes?
- Am I a candidate for breast-conserving survey? Why or why
not?
- How does my unique clinical and personal picture modify
those recommendations?
- Is this physician and hospital capable of doing immediate
reconstruction after surgery?
- What are the pros and cons of breast conserving surgery or
immediate reconstructive surgery?
Rates of Breast Conserving Surgery (by Region)*
Northeast 60.5%
North Central 51.1%
West 50.2%
South 48.0%
Caption: Breast cancer patients have the best chance of
immediate breast conserving surgery if they are treated in the
Northeast United States compared to other regions, according to the
recently released "100 Top Hospitals Clinical Research Study:
Management of Breast Cancer," conducted by the Solucient
Leadership Institute, formerly the HCIA-Sachs Institute.
Rates of Immediate Reconstructive Surgery Following Mastectomy
(by Age Group*)
Age 18 - 39 29.7%
Age 40 - 59 24.4%
Age 60 - 64 9.8%
Age 65 - 69 5.3%
Age 70 - 74 2.2%
Over 75 0.6%
Caption: Among breast cancer patients of all ages undergoing
inpatient mastectomy, younger patients were much more likely to
undergo immediate reconstruction than older patients, according to the
recently released "100 Top Hospitals Clinical Research Study:
Management of Breast Cancer," conducted by the Solucient
Leadership Institute, formerly the HCIA-Sachs Institute.
CONTACTS:
Solucient Leadership Institute Contact:
Jean Chenoweth, Executive Director
Phone: 734-669-7941
jchenoweth@solucient.com
Media Contact:
Kerry Lydon-Minton
Solucient LLC
Phone: 847-475-7526 ext. 2112
klydon@solucient.com
###
Home
> Media > News releases >
Breast Cancer |